Dr. Joel Avram Sercarz, MD

Dr. Sercarz practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Sercarz's NPI, 1013939784, was assigned on July 24, 2006. Dr. Sercarz graduated from David Geffen School of Medicine at UCLA in 1986. Dr. Sercarz's California license number on file is G62176.

Dr. Sercarz's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Sercarz's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Sercarz is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Head & Neck Associates. Dmand AI also links Dr. Sercarz to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sercarz practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Sercarz's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Sercarz is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Sercarz has a license on file in California.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, endoscopic sinus surgery, larynx and vocal cord disease, thyroid surgery and upper respiratory infection (URI) among the conditions Dr. Sercarz treats.

CMS data shows 473 Medicare services from Dr. Sercarz across 8 procedure codes in 2024, for 240 Medicare patients. Medicare paid $73,454 for them.

CMS counts 240 Medicare patients who saw Dr. Sercarz in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 28% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sercarz's median patient age at 61, with 49% women.

In 2024, Dr. Sercarz wrote 199 Medicare Part D claims for 100 patients. 93% of them were for generic drugs. CMS names the drug for 87 of them, across 4 drugs with 11 or more claims each, at $956 in total drug cost. In 2023, CMS named 129 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Sercarz for performance year 2024, reported as part of a group. Dr. Sercarz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 24 procedures of melanoma (skin cancer) excision by Dr. Sercarz, more than 77% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Sercarz, published from 2013 to 2021. Dr. Sercarz's most frequent co-authors are Karam W. Badran, MD, Dinesh Khatri Chhetri, MD and James W. Goodnight, MD.

CMS Open Payments shows 46 general payments to Dr. Sercarz from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 63% of the total. Intersect ENT, Inc. paid the most, $2,294.

Dmand AI lists 3 awards for Dr. Sercarz, most recently Top Doctors:LA Area in 2013.

Dr. Sercarz graduated from David Geffen School of Medicine at UCLA in 1986.

Dr. Sercarz is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.